UBL7

gene
On this page

Also known as BMSC-UbPMGC14421

Summary

UBL7 (ubiquitin like 7, HGNC:28221) is a protein-coding gene on chromosome 15q24.1, encoding Ubiquitin-like protein 7 (Q96S82). Interferon-stimulated protein that positively regulates RNA virus-triggered innate immune signaling.

Enables protein-macromolecule adaptor activity. Involved in antiviral innate immune response. Is active in cytoplasm.

Source: NCBI Gene 84993 — RefSeq curated summary.

At a glance

  • GWAS associations: 4
  • Clinical variants (ClinVar): 63 total
  • MANE Select transcript: NM_032907

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:28221
Approved symbolUBL7
Nameubiquitin like 7
Location15q24.1
Locus typegene with protein product
StatusApproved
AliasesBMSC-UbP, MGC14421
Ensembl geneENSG00000138629
Ensembl biotypeprotein_coding
OMIM609748
Entrez84993

Gene structure

Transcript identifiers

Ensembl transcripts: 45 — 45 protein_coding

ENST00000361351, ENST00000395081, ENST00000563081, ENST00000564488, ENST00000565130, ENST00000565335, ENST00000565494, ENST00000566365, ENST00000567435, ENST00000902154, ENST00000902155, ENST00000902156, ENST00000902157, ENST00000902158, ENST00000902159, ENST00000902160, ENST00000902161, ENST00000902162, ENST00000902163, ENST00000902164, ENST00000902165, ENST00000940643, ENST00000940644, ENST00000940645, ENST00000940646, ENST00000940647, ENST00000940648, ENST00000940649, ENST00000940650, ENST00000940651, ENST00000940652, ENST00000940653, ENST00000940654, ENST00000940655, ENST00000940656, ENST00000940657, ENST00000940658, ENST00000940659, ENST00000940660, ENST00000940661, ENST00000947580, ENST00000947581, ENST00000947582, ENST00000947583, ENST00000947584

RefSeq mRNA: 6 — MANE Select: NM_032907 NM_001286739, NM_001286740, NM_001286741, NM_001286742, NM_032907, NM_201265

CCDS: CCDS10263

Canonical transcript exons

ENST00000395081 — 11 exons

ExonStartEnd
ENSE000009319027444847874448600
ENSE000009319037444918674449353
ENSE000009319047444962674449675
ENSE000009319057444993674450069
ENSE000009319077445143674451520
ENSE000009319087445229674452378
ENSE000009319097445655274456671
ENSE000011107427444597774446227
ENSE000012598057445868474458896
ENSE000015205667446103774461160
ENSE000036064837445080274450859

Expression profiles

Bgee: expression breadth ubiquitous, 134 present calls, max score 96.92.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 29.4379 / max 336.6392, expressed in 1817 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
15091529.43791817

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primary visual cortexUBERON:000243696.92gold quality
prefrontal cortexUBERON:000045196.70gold quality
apex of heartUBERON:000209896.62gold quality
frontal cortexUBERON:000187096.30gold quality
hindlimb stylopod muscleUBERON:000425296.02gold quality
gastrocnemiusUBERON:000138895.95gold quality
superior frontal gyrusUBERON:000266195.91gold quality
right frontal lobeUBERON:000281095.87gold quality
cerebral cortexUBERON:000095695.63gold quality
Brodmann (1909) area 9UBERON:001354095.63gold quality
dorsolateral prefrontal cortexUBERON:000983495.56gold quality
bloodUBERON:000017895.53gold quality
anterior cingulate cortexUBERON:000983595.47gold quality
muscle of legUBERON:000138395.32gold quality
C1 segment of cervical spinal cordUBERON:000646994.81gold quality
Ammon’s hornUBERON:000195494.52gold quality
heart left ventricleUBERON:000208494.51gold quality
putamenUBERON:000187494.44gold quality
amygdalaUBERON:000187694.34gold quality
temporal lobeUBERON:000187194.33gold quality
substantia nigraUBERON:000203894.32gold quality
monocyteCL:000057694.16gold quality
leukocyteCL:000073894.14gold quality
right testisUBERON:000453494.05gold quality
granulocyteCL:000009493.99gold quality
left testisUBERON:000453393.92gold quality
muscle tissueUBERON:000238593.89gold quality
brainUBERON:000095593.82gold quality
skeletal muscle tissueUBERON:000113493.72gold quality
heartUBERON:000094893.63gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes7.40

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

18 targeting UBL7, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-4725-3P99.9669.532520
HSA-MIR-6780B-5P99.9669.602562
HSA-MIR-211099.9666.681930
HSA-MIR-4731-5P99.8967.232537
HSA-MIR-427199.8868.322244
HSA-MIR-430699.7270.503630
HSA-MIR-320299.6667.702737
HSA-MIR-361299.4566.021333
HSA-MIR-65099.4565.771309
HSA-MIR-185-5P99.3568.602497
HSA-MIR-6731-5P99.2867.422375
HSA-MIR-808599.2867.562362
HSA-MIR-6814-5P99.0366.681273
HSA-MIR-4772-3P98.0465.601203
HSA-MIR-450A-2-3P97.9167.561459
HSA-MIR-6836-3P97.0864.99712
HSA-MIR-59196.2968.16611

Literature-anchored findings (GeneRIF, showing 2)

  • BMSC-UbP might play roles in regulation of BMSC function or cell differentiation through an evocator- and cell-specific pattern. (PMID:12644319)
  • the solution NMR structure of the ubiquitin-associated domain of the human BMSC-UbP protein and its complex with ubiquitin (PMID:16731964)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_rerioubl7aENSDARG00000024229
danio_rerioubl7bENSDARG00000040286
mus_musculusUbl7ENSMUSG00000055720
rattus_norvegicusUbl7ENSRNOG00000007442
drosophila_melanogasterCG31528FBGN0051528

Paralogs (5): UBQLN1 (ENSG00000135018), UBQLN4 (ENSG00000160803), UBQLNL (ENSG00000175518), UBQLN3 (ENSG00000175520), UBQLN2 (ENSG00000188021)

Protein

Protein identifiers

Ubiquitin-like protein 7Q96S82 (reviewed: Q96S82)

Alternative names: Bone marrow stromal cell ubiquitin-like protein, Ubiquitin-like protein SB132

All UniProt accessions (5): Q96S82, H3BSE0, H3BSQ2, H3BUV9, H3BV23

UniProt curated annotations — full annotation on UniProt →

Function. Interferon-stimulated protein that positively regulates RNA virus-triggered innate immune signaling. Mechanistically, promotes ‘Lys-27’-linked polyubiquitination of MAVS through TRIM21 leading to enhanced the IFN signaling pathway.

Subunit / interactions. Binds ubiquitin. Interacts with MAVS; this interaction enhances TRIM21-dependent ‘Lys-27’-linked polyubiquitination of MAVS.

Tissue specificity. Ubiquitous. Highly expressed in heart, skeletal muscle, testis, thyroid and adrenal gland.

Post-translational modifications. Deubiquitinated by OTUD4 which stabilizes UBL7 expression.

Induction. By type I interferon. Down-regulated by phorbol myristate acetate (PMA) in bone marrow stroma cells.

RefSeq proteins (6): NP_001273668, NP_001273669, NP_001273670, NP_001273671, NP_116296, NP_957717 (=MANE)

Domains & families (InterPro)

IDNameType
IPR000626Ubiquitin-like_domDomain
IPR009060UBA-like_sfHomologous_superfamily
IPR015496UbiquilinFamily
IPR015940UBADomain
IPR029071Ubiquitin-like_domsfHomologous_superfamily
IPR047877UBL7_UblDomain
IPR047878UBL7_UBADomain

Pfam: PF00240

UniProt features (15 total): compositionally biased region 4, helix 3, domain 2, sequence conflict 2, chain 1, turn 1, region of interest 1, modified residue 1

Structure

Experimental structures (PDB)

2 structures.

PDBMethodResolution (Å)
2CWBSOLUTION NMR
2DENSOLUTION NMR

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96S82-F167.700.00

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 230

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 77 (showing top): GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOBP_DEFENSE_RESPONSE_TO_VIRUS, GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS, GOBP_PROTEIN_CATABOLIC_PROCESS, GOBP_RESPONSE_TO_VIRUS, GRYDER_PAX3FOXO1_TOP_ENHANCERS, GOBP_PROTEOLYSIS, GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_UP, GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN, DUAN_PRDM5_TARGETS, GOMF_POLYUBIQUITIN_MODIFICATION_DEPENDENT_PROTEIN_BINDING, GOMF_MODIFICATION_DEPENDENT_PROTEIN_BINDING, E2F2_TARGET_GENES, FOXJ2_TARGET_GENES

GO Biological Process (6): ubiquitin-dependent protein catabolic process (GO:0006511), antiviral innate immune response (GO:0140374), immune system process (GO:0002376), protein K27-linked ubiquitination (GO:0044314), innate immune response (GO:0045087), defense response to virus (GO:0051607)

GO Molecular Function (3): protein-macromolecule adaptor activity (GO:0030674), polyubiquitin modification-dependent protein binding (GO:0031593), protein binding (GO:0005515)

GO Cellular Component (2): cytoplasm (GO:0005737), cytosol (GO:0005829)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
protein ubiquitination1
modification-dependent protein catabolic process1
innate immune response1
defense response to virus1
biological_process1
protein polyubiquitination1
immune response1
defense response to symbiont1
defense response1
response to virus1
protein binding1
molecular adaptor activity1
modification-dependent protein binding1
binding1
intracellular anatomical structure1
cytoplasm1

Protein interactions and networks

STRING

3510 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
UBL7UBQLN2Q9UHD9836
UBL7UBQLN1Q9UMX0828
UBL7ZNF428Q96B54709
UBL7CIAPIN1Q6FI81629
UBL7CCDC33Q8N5R6629
UBL7MAS1P04201624
UBL7SLC44A3Q8N4M1534
UBL7CLK3P49761496
UBL7DDX49Q9Y6V7493
UBL7PRMT2IPQ6ZRI6479
UBL7UBAC1Q9BSL1478
UBL7UBL4AP11441477
UBL7NUB1Q9Y5A7469
UBL7RWDD1Q9H446462
UBL7ISLR2Q6UXK2452

IntAct

54 interactions, top by confidence:

ABTypeScore
VBP1UBL7psi-mi:“MI:0915”(physical association)0.830
UBL7VBP1psi-mi:“MI:0915”(physical association)0.830
UBL7AP1G1psi-mi:“MI:0915”(physical association)0.720
AP1G1UBL7psi-mi:“MI:0915”(physical association)0.720
UBL7ERCC1psi-mi:“MI:0915”(physical association)0.670
ERCC1UBL7psi-mi:“MI:0915”(physical association)0.670
VBP1PFDN6psi-mi:“MI:0914”(association)0.640
UBL7CAPN7psi-mi:“MI:0915”(physical association)0.560
CAPN7UBL7psi-mi:“MI:0915”(physical association)0.560
UBL7psi-mi:“MI:0915”(physical association)0.560
UBL7psi-mi:“MI:0915”(physical association)0.560
ERCC1UBL7psi-mi:“MI:0915”(physical association)0.560
RXRBUBL7psi-mi:“MI:0915”(physical association)0.560
ESRRGUBL7psi-mi:“MI:0915”(physical association)0.560
KDELR1TRAFD1psi-mi:“MI:0914”(association)0.530
UBL7psi-mi:“MI:0915”(physical association)0.520
UBL7psi-mi:“MI:0915”(physical association)0.520

BioGRID (100): UBL7 (Two-hybrid), UBL7 (Two-hybrid), UBL7 (Two-hybrid), UBL7 (Two-hybrid), UBB (Affinity Capture-MS), UBE4B (Affinity Capture-MS), AMY1C (Affinity Capture-MS), HDAC6 (Affinity Capture-MS), UBL7 (Two-hybrid), UBL7 (Two-hybrid), UBL7 (Affinity Capture-MS), DDX3X (Co-fractionation), HSPA4L (Co-fractionation), SNF8 (Co-fractionation), TLN2 (Co-fractionation)

ESM2 similar proteins: A1CDT9, A1DCU5, A3KMV2, F4JPR7, G5EFF7, O17453, O48726, O74803, P32628, P48510, P54725, P54726, P54727, P54728, P55035, Q0CJ13, Q0U3Y6, Q10169, Q1DNB9, Q1EBV4, Q28DG7, Q29RK4, Q2H085, Q2KIS3, Q2USD7, Q40742, Q4KMA2, Q4WGS4, Q54LV1, Q5AY89, Q5XIR9, Q5ZJI9, Q6NXA9, Q6NYI0, Q7K2G1, Q7S906, Q7ZXQ3, Q84L30, Q84L31, Q84L32

Diamond homologs: Q2KIS3, Q91W67, Q96S82, Q9UHD9

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

63 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance43
Likely benign2
Benign2

Top pathogenic / likely-pathogenic (0)

SpliceAI

1566 predictions. Top by Δscore:

VariantEffectΔscore
15:74449180:TCATA:Tdonor_loss1.0000
15:74449181:CATAC:Cdonor_loss1.0000
15:74449182:ATAC:Adonor_loss1.0000
15:74449183:TAC:Tdonor_loss1.0000
15:74449185:C:CGdonor_loss1.0000
15:74449349:GTGTT:Gacceptor_gain1.0000
15:74449350:TGTT:Tacceptor_gain1.0000
15:74449351:GTT:Gacceptor_gain1.0000
15:74449352:TT:Tacceptor_gain1.0000
15:74449353:TCTGG:Tacceptor_loss1.0000
15:74449354:C:CCacceptor_gain1.0000
15:74449624:A:ACdonor_gain1.0000
15:74449625:C:CCdonor_gain1.0000
15:74449931:CTCA:Cdonor_loss1.0000
15:74449933:CA:Cdonor_loss1.0000
15:74450065:CCAAC:Cacceptor_gain1.0000
15:74450066:CAAC:Cacceptor_gain1.0000
15:74450066:CAACC:Cacceptor_gain1.0000
15:74450070:CTA:Cacceptor_loss1.0000
15:74450071:T:Cacceptor_loss1.0000
15:74451431:CTTA:Cdonor_loss1.0000
15:74451432:TTACC:Tdonor_loss1.0000
15:74451433:TACCA:Tdonor_loss1.0000
15:74451434:A:ACdonor_gain1.0000
15:74451434:A:ATdonor_loss1.0000
15:74451435:C:CAdonor_loss1.0000
15:74451435:C:CCdonor_gain1.0000
15:74451521:C:CCacceptor_gain1.0000
15:74456550:AC:Adonor_gain1.0000
15:74456551:CC:Cdonor_gain1.0000

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000045651 (15:74452328 C>A,G,T), RS1000086766 (15:74445768 T>TG), RS1000168958 (15:74456971 A>G), RS1000401120 (15:74461624 T>C), RS1000410621 (15:74461460 C>G,T), RS1000636486 (15:74451143 C>T), RS1000841447 (15:74456182 C>T), RS1001134963 (15:74450101 G>A), RS1001225368 (15:74462776 C>A,T), RS1001334173 (15:74462034 A>G), RS1001618441 (15:74462418 C>A), RS1002180103 (15:74462096 A>C,G), RS1002294676 (15:74462346 C>G), RS1002372471 (15:74449069 C>T), RS1002476826 (15:74456043 T>C,G)

Disease associations

OMIM: gene MIM:609748 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

4 associations (top):

StudyTraitp-value
GCST004412_7Craniofacial microsomia1.000000e-23
GCST004865_16Itch intensity from mosquito bite adjusted by bite size6.000000e-08
GCST009391_1925Metabolite levels7.000000e-06
GCST90002382_325Eosinophil percentage of white cells3.000000e-09

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0008377mosquito bite reaction itch intensity measurement
EFO:0008378mosquito bite reaction size measurement
EFO:0010464beta-aminoisobutyric acid measurement
EFO:0007991eosinophil percentage of leukocytes

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

26 total (human), top 26 by PubMed support.

ChemicalActions (top 5)PubMed papers
FR900359increases phosphorylation1
bisphenol Fincreases expression, affects cotreatment1
triphenyl phosphateaffects expression1
pirinixic acidincreases activity, affects binding, decreases expression1
sodium arsenitedecreases expression1
coumarinincreases phosphorylation1
beta-methylcholineaffects expression1
CGP 52608affects binding, increases reaction1
K 7174decreases expression1
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amidedecreases expression, decreases reaction1
jinfukangincreases expression, affects cotreatment1
Sunitinibdecreases expression1
Vehicle Emissionsdecreases expression, decreases reaction1
Cisplatinaffects cotreatment, increases expression1
Dexamethasoneincreases expression, affects cotreatment1
Estradiolincreases expression1
Hydrogen Peroxideaffects expression1
Indomethacinaffects cotreatment, increases expression1
Leadaffects methylation1
Thiramdecreases expression1
Tretinoindecreases expression1
1-Methyl-3-isobutylxanthineaffects cotreatment, increases expression1
Cyclosporinedecreases expression1
Aflatoxin B1decreases methylation1
Lactic Aciddecreases expression1
Particulate Matterdecreases expression, decreases reaction1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): craniofacial microsomia